Back to School: How biopharma can reboot drug development. Access exclusive analysis here

AMD3100: Phase I

In a U.S. Phase I trial in 18 healthy volunteers, AMD3100 given

Read the full 124 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE